Skip to content
    NTLA stock page

    Intellia Therapeutics, Inc.

    NTLA · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 06, 2026

      Intellia Therapeutics Q2 FY26 — Positive Lonvo-z Phase III Results and Nex-z Clinical Progress

      Read the brief

    Browse all US companies on the earnings-call register.